Organoid-based models in cerebrovascular disorders: Mechanistic insights and precision medicine

Jiaxin Zhang1, Yiren Zhang1, Mengchen Yu1

  • 1Clinical Biobank Center, Guangdong Provincial Clinical Research Centre for Laboratory Medicine, Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510282, China; Neurosurgery Centre, Engineering Technology Research Centre of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, The National Key Clinical Specialty, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, The Neurosurgery Institute of Guangdong Province, Zhujiang Hospital Institute for Brain Science and Intelligence, The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510282, China.

Vascular Pharmacology
|August 14, 2026
PubMed

Insights

Organoid technology offers a novel in vitro platform for studying cerebrovascular diseases like stroke. This approach aids in understanding disease mechanisms, enabling early diagnosis, and developing new treatments.

Area of Science:

  • Biomedical research
  • Regenerative medicine
  • Neurology

Background:

  • Cerebrovascular diseases are a major global cause of death and disability.
  • Existing research models have limitations in fully replicating complex disease pathologies.
  • Organoid technology presents a promising advancement for in vitro disease modeling.

Purpose of the Study:

  • To review the current applications of organoid technology in cerebrovascular disease research.
  • To explore the establishment of organoid models for specific cerebrovascular conditions.
  • To discuss the potential and limitations of organoids in advancing precision medicine for these diseases.

Main Methods:

  • Literature review of studies utilizing organoid technology for cerebrovascular disease research.
  • Focus on organoid model establishment for cerebral cavernous malformations, ischemic stroke, and hemorrhagic stroke.
  • Analysis of mechanistic investigations and potential therapeutic applications.

Main Results:

  • Organoid models allow in vitro simulation of cerebrovascular disease pathogenesis.
  • They facilitate the study of angiogenesis and neurovascular unit interactions.
  • Organoids show potential for early diagnosis, target discovery, and drug development.

Conclusions:

  • Organoid technology provides a valuable platform for studying cerebrovascular diseases.
  • Further optimization and clinical validation are necessary for widespread application.
  • Organoids hold promise for advancing precision medicine in neurology and beyond.

Related Concept Videos